Health Secretary Robert F. Kennedy Jr. has appointed eight new members to the advisory immunization committee, including vaccine opponents, The Wall Street Journal’s Liz Essley Whyte and Dominique Mosbergen report. The new panel will review both new and existing vaccine recommendations. Kennedy’s move came two days after abruptly removing all 17 of the prior members of the Advisory Committee on Immunization Practices. “All of these individuals are committed to evidence-based medicine, gold-standard science, and common sense,” RFK Jr. said. Publicly traded companies in the pharmaceutical and vaccine space include Moderna (MRNA), Novavax (NVAX), BioNTech (BNTX), AstraZeneca (AZN), Bristol Myers (BMY), Eli Lilly (LLY), GSK (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRNA:
- Moderately bullish activity in Moderna with shares up 3.03%
- SPY ETF News, 6/11/2025
- Mixed options sentiment in Moderna with shares down 0.78%
- Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel
- RFK Jr. reconstituting vaccine advisory committee, retiring 17 current members